These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
192 related articles for article (PubMed ID: 3257221)
1. High [18F]FDG uptake in primary cerebral lymphoma: a PET study. Kuwabara Y; Ichiya Y; Otsuka M; Miyake Y; Gunasekera R; Hasuo K; Masuda K; Takeshita I; Fukui H J Comput Assist Tomogr; 1988; 12(1):47-8. PubMed ID: 3257221 [TBL] [Abstract][Full Text] [Related]
2. Studies of primary central nervous system lymphoma with fluorine-18-fluorodeoxyglucose positron emission tomography. Rosenfeld SS; Hoffman JM; Coleman RE; Glantz MJ; Hanson MW; Schold SC J Nucl Med; 1992 Apr; 33(4):532-6. PubMed ID: 1552337 [TBL] [Abstract][Full Text] [Related]
3. High [18F]-fluorodeoxyglucose uptake in abdominal abscesses: a PET study. Tahara T; Ichiya Y; Kuwabara Y; Otsuka M; Miyake Y; Gunasekera R; Masuda K J Comput Assist Tomogr; 1989; 13(5):829-31. PubMed ID: 2789238 [TBL] [Abstract][Full Text] [Related]
4. Ringlike uptake of [18F]FDG in brain abscess: a PET study. Sasaki M; Ichiya Y; Kuwabara Y; Otsuka M; Tahara T; Fukumura T; Gunasekera R; Masuda K J Comput Assist Tomogr; 1990; 14(3):486-7. PubMed ID: 2335626 [No Abstract] [Full Text] [Related]
5. Positron emission tomography using [18F] fluorodeoxyglucose in brain tumors. A powerful diagnostic and prognostic tool. Di Chiro G Invest Radiol; 1987 May; 22(5):360-71. PubMed ID: 3496318 [No Abstract] [Full Text] [Related]
6. Work in progress: [18F] fluorodeoxyglucose and positron emission tomography in the evaluation of radiation necrosis of the brain. Patronas NJ; Di Chiro G; Brooks RA; DeLaPaz RL; Kornblith PL; Smith BH; Rizzoli HV; Kessler RM; Manning RG; Channing M; Wolf AP; O'Connor CM Radiology; 1982 Sep; 144(4):885-9. PubMed ID: 6981123 [TBL] [Abstract][Full Text] [Related]
7. Uptake of fluorine-18-fluorodeoxyglucose in sarcoidosis. Lewis PJ; Salama A J Nucl Med; 1994 Oct; 35(10):1647-9. PubMed ID: 7931664 [TBL] [Abstract][Full Text] [Related]
8. Monitoring liver tumor therapy with [18F]FDG positron emission tomography. Nagata Y; Yamamoto K; Hiraoka M; Abe M; Takahashi M; Akuta K; Nishimura Y; Jo S; Masunaga S; Kubo S J Comput Assist Tomogr; 1990; 14(3):370-4. PubMed ID: 2335602 [TBL] [Abstract][Full Text] [Related]
10. Identification of early recurrence of primary central nervous system tumors by [18F]fluorodeoxyglucose positron emission tomography. Glantz MJ; Hoffman JM; Coleman RE; Friedman AH; Hanson MW; Burger PC; Herndon JE; Meisler WJ; Schold SC Ann Neurol; 1991 Apr; 29(4):347-55. PubMed ID: 1929205 [TBL] [Abstract][Full Text] [Related]
11. Non-invasive grading of primary brain tumours: results of a comparative study between SPET with 123I-alpha-methyl tyrosine and PET with 18F-deoxyglucose. Woesler B; Kuwert T; Morgenroth C; Matheja P; Palkovic S; Schäfers M; Vollet B; Schäfers K; Lerch H; Brandau W; Samnick S; Wassmann H; Schober O Eur J Nucl Med; 1997 Apr; 24(4):428-34. PubMed ID: 9096095 [TBL] [Abstract][Full Text] [Related]
12. [Validity of positron emission tomography (PET) using 2-deoxy-2-[18F]fluoro-D-glucose (FDG) in patients with renal cell carcinoma (preliminary report)]. Kawamura J; Hida S; Yoshida O; Yonekura Y; Senda M; Yamamoto K; Saji H; Fujita T; Konishi J Kaku Igaku; 1988 Oct; 25(10):1143-8. PubMed ID: 3265450 [No Abstract] [Full Text] [Related]
13. Use of [18F]fluorodeoxyglucose positron emission tomography in patients with primary malignant brain tumors. Janus TJ; Kim EE; Tilbury R; Bruner JM; Yung WK Ann Neurol; 1993 May; 33(5):540-8. PubMed ID: 8498831 [TBL] [Abstract][Full Text] [Related]
14. Differential diagnosis of idiopathic fibrosis from malignant lymphadenopathy with PET and F-18 fluorodeoxyglucose. Kubota K; Yamada K; Yoshioka S; Yamada S; Ito M; Ido T Clin Nucl Med; 1992 May; 17(5):361-3. PubMed ID: 1587040 [TBL] [Abstract][Full Text] [Related]
15. FDG-PET for predicting the prognosis of malignant lymphoma. Okada J; Oonishi H; Yoshikawa K; Itami J; Uno K; Imaseki K; Arimizu N Ann Nucl Med; 1994 Aug; 8(3):187-91. PubMed ID: 7811561 [TBL] [Abstract][Full Text] [Related]
16. Enhanced detection of brain tumors by [18F]fluorodeoxyglucose PET with glucose loading. Ishizu K; Sadato N; Yonekura Y; Nishizawa S; Magata Y; Tamaki N; Tsuchida T; Okazawa H; Tanaka F; Miyatake S J Comput Assist Tomogr; 1994; 18(1):12-5. PubMed ID: 8282860 [TBL] [Abstract][Full Text] [Related]
17. FDG-PET in differentiating lymphoma from nonmalignant central nervous system lesions in patients with AIDS. Hoffman JM; Waskin HA; Schifter T; Hanson MW; Gray L; Rosenfeld S; Coleman RE J Nucl Med; 1993 Apr; 34(4):567-75. PubMed ID: 8455072 [TBL] [Abstract][Full Text] [Related]
18. [Tomographic mapping of rate constants of [F-18] FDG model]. Sasaki H; Kanno I; Miura S; Murakami M; Takahashi K; Shishido F; Uemura K Kaku Igaku; 1985 Jan; 22(1):81-4. PubMed ID: 3873558 [No Abstract] [Full Text] [Related]
19. [An analysis of 18FDG kinetic rate constants using dynamic positron emission tomography in human brain tumors]. Yamaguchi T; Sasaki H; Uemura K; Shishido F; Inugami A; Ogawa T; Higano S; Mineura K; Kanno I; Murakami M Kaku Igaku; 1986 Jun; 23(6):829-32. PubMed ID: 3489854 [No Abstract] [Full Text] [Related]